Cargando…

Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity

Violacein (Viol) is a bacterial purple water-insoluble pigment synthesized by Chromobacterium violaceum and other microorganisms that display many beneficial therapeutic properties including anticancer activity. Viol was produced, purified in our laboratory, and encapsulated in a nanostructured lipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivero Berti, Ignacio, Rodenak-Kladniew, Boris E., Katz, Sergio F., Arrua, Eva Carolina, Alvarez, Vera A., Duran, Nelson, Castro, Guillermo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301079/
https://www.ncbi.nlm.nih.gov/pubmed/35873038
http://dx.doi.org/10.3389/fchem.2022.914126
_version_ 1784751352745820160
author Rivero Berti, Ignacio
Rodenak-Kladniew, Boris E.
Katz, Sergio F.
Arrua, Eva Carolina
Alvarez, Vera A.
Duran, Nelson
Castro, Guillermo R.
author_facet Rivero Berti, Ignacio
Rodenak-Kladniew, Boris E.
Katz, Sergio F.
Arrua, Eva Carolina
Alvarez, Vera A.
Duran, Nelson
Castro, Guillermo R.
author_sort Rivero Berti, Ignacio
collection PubMed
description Violacein (Viol) is a bacterial purple water-insoluble pigment synthesized by Chromobacterium violaceum and other microorganisms that display many beneficial therapeutic properties including anticancer activity. Viol was produced, purified in our laboratory, and encapsulated in a nanostructured lipid carrier (NLC). The NLC is composed of the solid lipid myristyl myristate, an oily lipid mixture composed of capric and caprylic acids, and the surfactant poloxamer P188. Dormant lipase from Rhizomucor miehei was incorporated into the NLC-Viol to develop an active release system. The NLC particle size determined by dynamic light scattering brings around 150 nm particle size and ζ≈ −9.0 mV with or without lipase, but the incorporation of lipase increase the PdI from 0.241 to 0.319 (≈32%). For scaffold development, a 2.5 hydroxypropyl methylcellulose/chitosan ratio was obtained after optimization of a composite for extrusion in a 3D-bioprinter developed and constructed in our laboratory. Final Viol encapsulation efficiency in the printings was over 90%. Kinetic release of the biodye at pH = 7.4 from the mesh containing NLC-lipase showed roughly 20% Viol fast release than without the enzyme. However, both Viol kinetic releases displayed similar profiles at pH = 5.0, where the lipase is inactive. The kinetic release of Viol from the NLC-matrices was modeled and the best correlation was found with the Korsmeyer-Peppas model (R(2) = 0.95) with n < 0.5 suggesting a Fickian release of Viol from the matrices. Scanning Electron Microscope (SEM) images of the NLC-meshes showed significant differences before and after Viol’s release. Also, the presence of lipase dramatically increased the gaps in the interchain mesh. XRD and Fourier Transform Infrared (FTIR) analyses of the NLC-meshes showed a decrease in the crystalline structure of the composites with the incorporation of the NLC, and the decrease of myristyl myristate in the mesh can be attributed to the lipase activity. TGA profiles of the NLC-meshes showed high thermal stability than the individual components. Cytotoxic studies in A549 and HCT-116 cancer cell lines revealed high anticancer activity of the matrix mediated by mucoadhesive chitosan, plus the biological synergistic activities of violacein and lipase.
format Online
Article
Text
id pubmed-9301079
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93010792022-07-22 Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity Rivero Berti, Ignacio Rodenak-Kladniew, Boris E. Katz, Sergio F. Arrua, Eva Carolina Alvarez, Vera A. Duran, Nelson Castro, Guillermo R. Front Chem Chemistry Violacein (Viol) is a bacterial purple water-insoluble pigment synthesized by Chromobacterium violaceum and other microorganisms that display many beneficial therapeutic properties including anticancer activity. Viol was produced, purified in our laboratory, and encapsulated in a nanostructured lipid carrier (NLC). The NLC is composed of the solid lipid myristyl myristate, an oily lipid mixture composed of capric and caprylic acids, and the surfactant poloxamer P188. Dormant lipase from Rhizomucor miehei was incorporated into the NLC-Viol to develop an active release system. The NLC particle size determined by dynamic light scattering brings around 150 nm particle size and ζ≈ −9.0 mV with or without lipase, but the incorporation of lipase increase the PdI from 0.241 to 0.319 (≈32%). For scaffold development, a 2.5 hydroxypropyl methylcellulose/chitosan ratio was obtained after optimization of a composite for extrusion in a 3D-bioprinter developed and constructed in our laboratory. Final Viol encapsulation efficiency in the printings was over 90%. Kinetic release of the biodye at pH = 7.4 from the mesh containing NLC-lipase showed roughly 20% Viol fast release than without the enzyme. However, both Viol kinetic releases displayed similar profiles at pH = 5.0, where the lipase is inactive. The kinetic release of Viol from the NLC-matrices was modeled and the best correlation was found with the Korsmeyer-Peppas model (R(2) = 0.95) with n < 0.5 suggesting a Fickian release of Viol from the matrices. Scanning Electron Microscope (SEM) images of the NLC-meshes showed significant differences before and after Viol’s release. Also, the presence of lipase dramatically increased the gaps in the interchain mesh. XRD and Fourier Transform Infrared (FTIR) analyses of the NLC-meshes showed a decrease in the crystalline structure of the composites with the incorporation of the NLC, and the decrease of myristyl myristate in the mesh can be attributed to the lipase activity. TGA profiles of the NLC-meshes showed high thermal stability than the individual components. Cytotoxic studies in A549 and HCT-116 cancer cell lines revealed high anticancer activity of the matrix mediated by mucoadhesive chitosan, plus the biological synergistic activities of violacein and lipase. Frontiers Media S.A. 2022-07-07 /pmc/articles/PMC9301079/ /pubmed/35873038 http://dx.doi.org/10.3389/fchem.2022.914126 Text en Copyright © 2022 Rivero Berti, Rodenak-Kladniew, Katz, Arrua, Alvarez, Duran and Castro. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Rivero Berti, Ignacio
Rodenak-Kladniew, Boris E.
Katz, Sergio F.
Arrua, Eva Carolina
Alvarez, Vera A.
Duran, Nelson
Castro, Guillermo R.
Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity
title Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity
title_full Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity
title_fullStr Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity
title_full_unstemmed Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity
title_short Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity
title_sort enzymatic active release of violacein present in nanostructured lipid carrier by lipase encapsulated in 3d-bioprinted chitosan-hydroxypropyl methylcellulose matrix with anticancer activity
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301079/
https://www.ncbi.nlm.nih.gov/pubmed/35873038
http://dx.doi.org/10.3389/fchem.2022.914126
work_keys_str_mv AT riverobertiignacio enzymaticactivereleaseofviolaceinpresentinnanostructuredlipidcarrierbylipaseencapsulatedin3dbioprintedchitosanhydroxypropylmethylcellulosematrixwithanticanceractivity
AT rodenakkladniewborise enzymaticactivereleaseofviolaceinpresentinnanostructuredlipidcarrierbylipaseencapsulatedin3dbioprintedchitosanhydroxypropylmethylcellulosematrixwithanticanceractivity
AT katzsergiof enzymaticactivereleaseofviolaceinpresentinnanostructuredlipidcarrierbylipaseencapsulatedin3dbioprintedchitosanhydroxypropylmethylcellulosematrixwithanticanceractivity
AT arruaevacarolina enzymaticactivereleaseofviolaceinpresentinnanostructuredlipidcarrierbylipaseencapsulatedin3dbioprintedchitosanhydroxypropylmethylcellulosematrixwithanticanceractivity
AT alvarezveraa enzymaticactivereleaseofviolaceinpresentinnanostructuredlipidcarrierbylipaseencapsulatedin3dbioprintedchitosanhydroxypropylmethylcellulosematrixwithanticanceractivity
AT durannelson enzymaticactivereleaseofviolaceinpresentinnanostructuredlipidcarrierbylipaseencapsulatedin3dbioprintedchitosanhydroxypropylmethylcellulosematrixwithanticanceractivity
AT castroguillermor enzymaticactivereleaseofviolaceinpresentinnanostructuredlipidcarrierbylipaseencapsulatedin3dbioprintedchitosanhydroxypropylmethylcellulosematrixwithanticanceractivity